Matthew N Hill Selected Research

Matthew N Hill Research Topics

Disease

9	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 12/2009
6	Mental Disorders (Mental Disorder) 01/2021 - 08/2006
4	Obesity 01/2020 - 01/2015
3	Cannabinoid Hyperemesis Syndrome 01/2022 - 01/2020
3	Nausea 01/2022 - 01/2020
3	Seizures (Absence Seizure) 01/2021 - 01/2020
3	Wounds and Injuries (Trauma) 01/2021 - 01/2018
3	Anxiety Disorders (Anxiety Disorder) 08/2019 - 12/2009
3	Schizophrenia (Dementia Praecox) 12/2018 - 06/2010
3	Cognitive Dysfunction 01/2017 - 03/2005
3	Mood Disorders (Mood Disorder) 05/2014 - 08/2008
2	Colitis 01/2021 - 01/2021
2	Epilepsy (Aura) 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 12/2019
2	Weight Gain 01/2020 - 01/2015
2	Personality Disorders (Personality Disorder) 12/2019 - 01/2018
1	Vomiting 01/2022
1	Pulmonary Tuberculosis 01/2022
1	Stroke (Strokes) 01/2021
1	Absence Epilepsy (Childhood Absence Epilepsy) 01/2021
1	Neuroblastoma 01/2020
1	Marijuana Abuse (Cannabis Abuse) 01/2020
1	Substance-Related Disorders (Drug Abuse) 01/2020
1	Chronic Pain 08/2019
1	Pain (Aches) 08/2019
1	Postoperative Pain 08/2019
1	Anorexia 01/2019
1	Body Weight (Weight, Body) 01/2018
1	Genomic Instability 10/2015
1	Treatment-Resistant Depressive Disorder 02/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015
1	Dyslipidemias (Dyslipidemia) 01/2015
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2013
1	Autoimmune Diseases of the Nervous System 10/2013
1	Sleep Deprivation 06/2010
1	Serotonin Syndrome (Syndrome, Serotonin) 06/2006

Drug/Important Bio-Agent (IBA)

26	EndocannabinoidsIBA 01/2022 - 08/2006
7	CannabinoidsIBA 01/2021 - 03/2005
6	anandamide (arachidonylethanolamide)IBA 01/2020 - 06/2010
5	Pharmaceutical PreparationsIBA 07/2020 - 08/2016
4	Dronabinol (THC)FDA LinkGeneric 01/2022 - 01/2020
4	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2021 - 08/2019
4	GlucocorticoidsIBA 01/2021 - 12/2013
3	CorticosteroneIBA 01/2021 - 01/2015
2	CannabidiolIBA 01/2022 - 01/2021
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021 - 12/2009
2	Hormones (Hormone)IBA 01/2021 - 01/2020
2	Sulfonic AcidsIBA 01/2021 - 01/2021
2	CytokinesIBA 01/2021 - 10/2013
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2020 - 01/2015
2	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 12/2019 - 01/2018
2	LeptinIBA 01/2018 - 01/2015
1	5-HT1A Serotonin ReceptorIBA 01/2022
1	Lithium ChlorideIBA 01/2022
1	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2022
1	EnzymesIBA 01/2021
1	InterleukinsIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	ProstaglandinsIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	sym-trinitrobenzeneIBA 01/2021
1	Interleukin-9 (Interleukin 9)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Monocyte Chemoattractant ProteinsIBA 01/2021
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2021
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2021
1	Leukemia Inhibitory FactorIBA 01/2021
1	Biological ProductsIBA 01/2021
1	AntiemeticsIBA 07/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Ghrelin ReceptorsIBA 01/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	1-pentyl-3-(1-naphthoyl)indoleIBA 01/2020
1	1-dodecylpyridoxal (PLD)IBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	GhrelinIBA 01/2020
1	picolinic acid (chromium picolinate)IBA 12/2019
1	Interleukin-6 (Interleukin 6)IBA 12/2019
1	KynurenineIBA 12/2019
1	Analgesics (Analgesic Drugs)IBA 08/2019
1	Glycerol (Glycerine)FDA LinkGeneric 01/2019
1	N- pyridazin- 3- yl- 4- (3- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)benzylidene)piperidine- 1- carboxamideIBA 01/2019
1	Retroelements (Retrotransposon)IBA 10/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2015
1	AM 251 (AM251)IBA 01/2015
1	Insulin (Novolin)FDA Link 01/2015
1	SmokeIBA 03/2014
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2013
1	Myelin-Oligodendrocyte GlycoproteinIBA 10/2013
1	Peptides (Polypeptides)IBA 10/2013
1	HU 211 (HU 210)IBA 06/2006

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2018 - 12/2009
1	Subcutaneous Injections 01/2022
1	Injections 01/2020
1	Analgesia 08/2019
1	Self Medication 01/2018
1	Aftercare (After-Treatment) 01/2018
1	Deep Brain Stimulation 02/2015